Does vitamin B3 boost help lupus symptoms?
Treatments studied
Part of Immune system & allergy, Skin clinical trials.
This study tests whether a form of vitamin B3, called nicotinamide riboside, can improve immune function and reduce inflammation in women with mild to moderate lupus. It may help understand if boosting NAD+ levels offers a new way to manage the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman age 18 or older with lupus that is mild to moderate in activity.
- If you take steroids, your dose must be 20 mg or less daily and stable for the last 4 weeks.
- If you take hydroxychloroquine or other antimalarials, your dose must be stable for the last 12 weeks.
- If you take immunosuppressive drugs like methotrexate or mycophenolate mofetil, your dose must be stable for the last 12 weeks.
- You must agree to use effective birth control during the study if you could become pregnant.
- You must be willing to stop any vitamin B3 or tryptophan supplements at least 6 weeks before starting.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment for people with active lupus who haven't responded well to steroids and at least two other immune-suppressing drugs, including a biologic. It aims to find a better option for controlling lupus symptoms.
This study tests a new injectable medicine (SG301) for people with lupus (SLE) whose current treatments are not working well enough or cause side effects. It aims to see if this targeted therapy can better control lupus symptoms.
This early-phase trial tests a new drug called TI-0032-III for people with several autoimmune diseases that haven't gotten better with standard treatments. It aims to see if the drug can safely reduce disease activity and offer a new option for people who have few choices left.
This research study aims to better understand systemic lupus erythematosus (SLE), an autoimmune disease where the body's immune system attacks its own tissues. Researchers will evaluate patients with lupus, study genetic factors, and perform optional imaging tests to learn how the disease affects blood vessels and the heart.
This study looks at whether a “methyl-donor” nutrient supplement changes metabolism (methylation) in people with lupus who are also in the childbearing age range and have low-to-moderate disease activity. It may help researchers understand why lupus acts differently in some people and how diet-related pathways could affect symptoms.
This trial tests if taking a vitamin B3 supplement (nicotinamide) can improve outcomes for people with rheumatoid arthritis. Researchers want to see if adding this over-the-counter vitamin to your usual arthritis medicines helps reduce disease activity.
Hear when a new Systemic Lupus Erythematosus (Sle) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.